Publicaciones en colaboración con investigadores/as de Medical University of Vienna (4)

2024

  1. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

    Ophthalmology

2023

  1. Blue Light Exposure: Ocular Hazards and Prevention—A Narrative Review

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 755-788

2021

  1. Exploring consensus on preventive measures and identification of patients at risk of age-related macular degeneration using the delphi process

    Journal of Clinical Medicine, Vol. 10, Núm. 22

2018

  1. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

    JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677